Evidence map›Paper›PMID 39534277›Full record

ArticlePhysics and imaging in radiation oncology2024

Monte Carlo simulated correction factors for high dose rate brachytherapy postal dosimetry audit methodology.

Krzysztof Chelminski, Alexis Dimitriadis, Roua Abdulrahim, Pavel Kazantsev, Evelyn Granizo-Roman, Jonathan Kalinowski, Shirin Abbasi Enger, Godfrey Azangwe, Mauro Carrara, Jamema Swamidas

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Breakthroughs in modern brachytherapy are transforming cancer care.Physics and imaging in radiation oncology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Krzysztof ChelminskiInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Alexis DimitriadisInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Roua AbdulrahimInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Pavel KazantsevInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Evelyn Granizo-RomanInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Jonathan KalinowskiMcGill University, Department of Oncology, Medical Physics Unit, Montreal, Canada.
Shirin Abbasi EngerMcGill University, Department of Oncology, Medical Physics Unit, Montreal, Canada.
Godfrey AzangweInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Mauro CarraraInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.
Jamema SwamidasInternational Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Full-scatter conditions in water are impractical for postal dosimetry audits in brachytherapy. This work presents a method to obtain correction factors that account for deviations from full-scatter water-equivalent conditions for a small plastic phantom. Material and Methods: A 16 × 8 × 3 cm phantom (PMMA) with a radiophotoluminescent dosimeter (RPLD) at the centre and two catheters on either side was simulated using Monte Carlo (MC) to calculate correction factors accounting for the lack of scatter, non-water equivalence of the RPLD and phantom, source model and backscatter for HDR Results: The correction factors for non-water equivalence, lack of full scatter, and the use of PMMA were 1.062 ± 0.013, 1.059 ± 0.008 and 0.993 ± 0.009 for Conclusions: Correction factors were obtained through the MC simulations for conditions deviating from TG-43, including the amount of back scatter, and the optimum audit set up. Additionally, the influence of different source models on the correction factors was negligible and demonstrates their generic applicability.

Indexed as

BrachytherapyDosimetry auditMonte Carlo simulationsReference Air Kerma Rate

Identifiers

PMID39534277
PMCPMC11554633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.